Figure 5From: Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive reviewEffect of addition of montelukast (10 mg/d) or doubling the dose of ICS on morning peak expiratory flow (AM PEF) over 12 week treatment period in patients not adequately controlled by budesonide 800 μg/d (solid line = montelukast + budesonide 800 mg/d, dashed line = budesonide 1600 μg/d) (with permission from ref 93).Back to article page